Cryo cell International Inc   (CCEL)
Other Ticker:  
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
Price: $4.9600 $0.10 2.058%
Day's High: $5.11 Week Perf: -7.12 %
Day's Low: $ 4.70 30 Day Perf: -5.88 %
Volume (M): 8 52 Wk High: $ 7.25
Volume (M$): $ 39 52 Wk Avg: $5.14
Open: $4.90 52 Wk Low: $2.69

 Market Capitalization (Millions $) 41
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 31
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 5

Cryo Cell International Inc
Cryo Cell International Inc is a biotechnology company that specializes in providing cord blood and cord tissue banking services. Cord blood banking involves the collection and preservation of stem cells found in the umbilical cord after childbirth, while cord tissue banking involves the preservation of stem cells found in the umbilical cord tissue.

The company operates laboratories and storage facilities where they process and store the collected samples in a cryogenic state, ensuring their long-term viability and potential use in regenerative medicine and future medical treatments. Cryo Cell International Inc offers these services to expecting parents, allowing them to store their child's cord blood and cord tissue for potential future therapeutic applications.

The company is committed to maintaining high-quality standards in their operations and adheres to stringent regulations and guidelines in the field of stem cell banking. They also conduct research and collaborate with medical professionals and scientists to advance the understanding and applications of stem cells in various medical fields.

Cryo Cell International Inc aims to contribute to the growing field of regenerative medicine by providing a reliable and secure means of preserving stem cells for potential use in treating a wide range of diseases and medical conditions.

   Company Address: 700 Brooker Creek Blvd Oldsmar 34677 FL
   Company Phone Number: 749-2100   Stock Exchange / Ticker: NYSEAMER CCEL


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Cryo Cell International Inc

Cryo Cell International Inc's Impressive 2.46% Growth Spurs Investor Activity in Q3 2023

Over the past five trading days, Cryo Cell International Inc has experienced a significant drop in its stock value. However, the company's year-to-date performance remains positive, and its financial results, released for the period ending August 31, 2023, indicate several positive developments. This article will analyze these financial results and evaluate their potential impact on the company's future.
1. Increasing Profitability:
Cryo Cell International Inc's profit per share has significantly increased by 33.33% to $0.08. In comparison to the previous year ($0.06 per share), this growth highlights the company's improving financial health. Additionally, the earnings per share (EPS) surged by an impressive 166.67%, reaching $0.03 per share from the prior reporting period.

Cryo Cell International Inc

Cryo Cell International Faces Earnings Dip Despite 1.827% Revenue Boost in Q2 2023

Cryo Cell International Inc, a leading cellular therapy company, has reported its financial results for the period March to May 31, 2023. While the company witnessed a positive revenue advancement of 1.827%, it unfortunately experienced a significant income decline of -57.14% compared to the same reporting period the previous year. This article will analyze the key financial figures and assess the implications for Cryo Cell International Inc.
Financial Results Overview:
During the reported period, Cryo Cell International Inc generated revenue of $7.77 million, representing a marginal decrease of -0.661% compared to the prior reporting period. The earnings per share (EPS) stood at $0.03, reflecting a substantial decline of -66.67% from $0.09 per share in the corresponding period the previous year.


Cryo Cell International Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com